查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1624434

研究用抗體的全球市場規模:各技術，各終端用戶，各產品，各用途，各地區，範圍及預測

Global Research Antibodies Market Size By Technology, By End User, By Product, By Application, By Geographic Scope And Forecast
出版日期: | 出版商: Verified Market Research | 英文 202 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

研究抗體的市場規模及預測

2021 年研究抗體市場規模價值 108.7 億美元，預計到 2030 年將達到 195.5 億美元，2023 年至 2030 年的複合年增長率為 6.75%。各國政府為蛋白質體學和基因組學研究提供了巨額資金，從而帶動全球研究抗體市場蓬勃發展。全球研究抗體市場報告對市場進行了全面的評估。它對關鍵細分市場、趨勢、市場推動因素、競爭格局以及在市場中發揮關鍵作用的因素進行了全面的分析。

全球研究抗體市場定義

B 細胞產生的蛋白質稱為抗體。這些 B 細胞是人體免疫系統的一部分。抗體的主要功能是附著於抗原並標記它以供破壞。這有助於抵抗感染。研究抗體可以與特定分子結合，使其成為研究細胞的理想探針。研究抗體是研究細胞內蛋白質功能的重要工具。

全球研究抗體市場概論

全球研究抗體市場的成長是由不斷增加的研究活動所推動的。公司對研發活動投入了大量資金。產學合作的加強也促進了全球研究抗體市場的快速成長。印度和中國等新興市場預計將為市場成長創造新的機會。然而，與上述推動因素相反，也存在一些限制市場成長的因素。對結果品質和缺乏可重複性的擔憂可能會對市場成長產生負面影響。

目錄

第1章 全球研究用抗體市場簡介

  • 市場概要
  • 調查範圍
  • 前提條件

第2章 摘要整理

第3章 VERIFIED MARKET RESEARCH的調查手法

  • 資料探勘
  • 驗證
  • 第一手資料
  • 資料來源一覽

第4章 全球研究用抗體市場展望

  • 概要
  • 市場動態
    • 促進因素
    • 阻礙因素
    • 機會
  • 波特的五力分析
  • 價值鏈分析
  • 法律規範

第5章 研究用抗體的全球市場:各技術

  • 西方印漬術
  • 流式細胞技術
  • 酵素結合免疫吸附檢測法(ELISA)
  • 免疫組織化學
  • 免疫螢光法
  • 免疫沉澱
  • 其他技術

第6章 研究用抗體的全球市場:各終端用戶

  • 製藥·生物科技企業
  • 學術·研究機關
  • 受託研究機構

第7章 研究用抗體的全球市場:各產品

  • 試劑
    • 培養基·血清
    • 染色·色素
    • 固定化劑
    • 緩衝液
    • 溶媒
    • 酵素
    • 探針
    • 其他的試劑
  • 抗體
    • 各類型
    • 各來源
    • 各研究領域

第8章 研究用抗體的全球市場:各用途

  • 蛋白質體學
  • 醫藥品開發
  • 基因學

第9章 研究用抗體的全球市場:各地區

  • 概要
  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 其他歐洲
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 其他亞太地區
  • 全球其他地區
    • 南美
    • 中東·非洲

第10章 全球研究用抗體市場競爭情形

  • 概要
  • 各公司的市場佔有率
  • 業者情勢
  • 主要的開發策略

第11章 企業簡介

  • Thermo Fisher Scientific Inc.
  • Merck Group
  • Abcam PLC
  • Becton, Dickinson and Company
  • Cell Signaling Technology, Inc.
  • Bio-Rad Laboratories, Inc.
  • F. Hoffmann-La Roche Ltd
  • Agilent Technologies, Inc.
  • Danaher Corporation
  • Lonza
  • Genscript
  • Perkinelmer, Inc.
  • Biolegend, Inc.

第12章 主要發展

  • 產品的上市/開發
  • 合併和收購
  • 事業擴大
  • 夥伴關係和合作

第13章 附錄

  • 相關調查
簡介目錄
Product Code: 24330

Research Antibodies Market Size And Forecast

Research Antibodies Market size was valued at USD 10.87 Billion in 2021 and is projected to reach USD 19.55 Billion by 2030, growing at a CAGR of 6.75% from 2023 to 2030. The governments are providing huge funds to proteomics and genomics research and that has led to the global Research Antibodies Market growing at a rapid pace. The Global Research Antibodies Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Research Antibodies Market Definition

The proteins which are made up of B cells are called antibodies. These B cells are part of the body's immune system. The primary function of the antibodies is to latch on to antigens and flag them for destruction. This helps in fighting infection. The research antibodies can bind specific molecules which makes them ideal probes in cell research. Research antibodies are an important tool when it comes to studying protein functions in cells.

Global Research Antibodies Market Overview

The growth of the Global Research Antibodies Market is being driven by increasing research activities. The companies are investing heavily in research and development activities. The growing industry-academia collaboration has also led to the rapid growth of the Global Research Antibodies Market. Emerging markets such as India and China will create new opportunities for the market to grow. However, contrary to the above drivers some restraints will limit the growth of the market. The concerns related to quality and lack of reproducible results will negatively influence the growth of the market.

Global Research Antibodies Market: Segmentation Analysis

The Global Research Antibodies Market is Segmented on the basis of Technology, End User, Product, Application, And Geography.

Research Antibodies Market, By Technology

  • Western Blotting
  • Flow Cytometry
  • Enzyme-Linked Immunosorbent Assay (ELISA)
  • Immunohistochemistry
  • Immunofluorescence
  • Immunoprecipitation
  • Other Technologies

Based on Technology, the market is bifurcated into Western Blotting, Flow Cytometry, Enzyme-Linked Immunosorbent Assay (ELISA), Immunohistochemistry, Immunofluorescence, Immunoprecipitation, and Other Technologies. The flow cytometry segment is dominating the market owing to its ability to perform simultaneous multi-parameter analysis on a single cell within a heterogeneous mixture.

Research Antibodies Market, By End User

  • Pharmaceutical and Biotechnology Companies
  • Academic and Research Institutes
  • Contract Research Organizations

Based on End User, the market is bifurcated into Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, and Contract Research Organizations. The pharmaceutical and biotechnology companies contributed majorly to the growth of the market as research antibodies are widely being used for drug development.

Research Antibodies Market, By Product

  • Reagents
  • Antibodies

Based on Product, the market is bifurcated into Reagents and Antibodies. The reagents segment is further bifurcated into Media & Sera, Stains & Dyes, Fixatives, Buffers, Solvents, Enzymes, Probes, and Other Reagents. The antibodies segment is further bifurcated into By Type, By Source, and By Research Area.

Research Antibodies Market, By Application

  • Proteomics
  • Drug Development
  • Genomics

Based on Application, the market is bifurcated into Proteomics, Drug Development, and Genomics. The proteomics segment dominated the market as it was able to effectively minimize the cost, time, and resource requirement for chemical synthesis and biological testing of drugs.

Research Antibodies Market, By Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of the world
  • On the basis of Regional Analysis, the Global Research Antibodies Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. The largest share of the market will be dominated by North America. The dominance of the North American region is credited to the increasing investment in the development of structure-based drug designs.

Key Players

  • The "Global Research Antibodies Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are
  • Thermo Fisher Scientific Inc., Merck Group, Abcam PLC, Becton, Dickinson and Company, Cell Signaling Technology, Inc., Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd, Agilent Technologies, Inc., Danaher Corporation, Lonza, Genscript, Perkinelmer, Inc., Biolegend, Inc.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Key Developments

  • Partnerships, Collaborations and Agreements
  • In 2018, Thermo Fisher Scientific Inc., collaborated with Montreal Neurological Institute with an aim to develop improved and new methods to both characterize and produce antibodies for advanced neurological research associated with Amyotrophic lateral sclerosis, Parkinson's disease, and other brain diseases.
  • In 2020, Thermo Fisher Scientific (US) collaborated with Wuxi and Mayo Clinic To secure FDA authorization for testing COVID-19 with ELISA for detecting both IgM and IgG antibodies.
  • Mergers and Acquisitions
  • On September 2018, Roche announced the acquisition of Tusk Therapeutic Ltd. Tusk is a developer of an antibody that has a novel mode of action aimed at depleting regulatory T cells.
  • In 2019, Thermo Fisher Scientific (US) acquired Brammer Bio (US) to expand its capacity for manufacturing viral vectors for gene and cell therapies with Brammer Bio's CDMO facilities. The acquisition was valued at USD 1.7 billion.
  • Product Launches and Product Expansions
  • On October 2021, Thermo Fisher Scientific, the world leader in serving science, has launched a new CE-IVD-marked COVID-19 test. The TaqPath COVID-19 Fast PCR Combo Kit 2.0. expands Thermo Fisher's menu of highly accurate tests that detect active SARS-CoV-2 infections.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL RESEARCH ANTIBODIES MARKET

  • 1.1 Overview of the Market
  • 1.2 Scope of Report
  • 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

  • 3.1 Data Mining
  • 3.2 Validation
  • 3.3 Primary Interviews
  • 3.4 List of Data Sources

4 GLOBAL RESEARCH ANTIBODIES MARKET OUTLOOK

  • 4.1 Overview
  • 4.2 Market Dynamics
    • 4.2.1 Drivers
    • 4.2.2 Restraints
    • 4.2.3 Opportunities
  • 4.3 Porters Five Force Model
  • 4.4 Value Chain Analysis
  • 4.5 Regulatory Framework

5 GLOBAL RESEARCH ANTIBODIES MARKET, BY TECHNOLOGY

  • 5.1 Western Blotting
  • 5.2 Flow Cytometry
  • 5.3 Enzyme-Linked Immunosorbent Assay (ELISA)
  • 5.4 Immunohistochemistry
  • 5.5 Immunofluorescence
  • 5.6 Immunoprecipitation
  • 5.7 Other Technologies

6 GLOBAL RESEARCH ANTIBODIES MARKET, BY END USER

  • 6.1 Pharmaceutical and Biotechnology Companies
  • 6.2 Academic and Research Institutes
  • 6.3 Contract Research Organizations

7 GLOBAL RESEARCH ANTIBODIES MARKET, BY PRODUCT

  • 7.1 Reagents
    • 7.1.1 Media & Sera
    • 7.1.2 Stains & Dyes
    • 7.1.3 Fixatives
    • 7.1.4 Buffers
    • 7.1.5 Solvents
    • 7.1.6 Enzymes
    • 7.1.7 Probes
    • 7.1.8 Other Reagents
  • 7.2 Antibodies
    • 7.2.1 By Type
    • 7.2.1.1 Primary Antibodies
    • 7.2.1.2 Secondary Antibodies
    • 7.2.2 By Source
    • 7.2.2.1 Mice
    • 7.2.2.2 Rabbits
    • 7.2.2.3 Other Sources
    • 7.2.3 By Research Area
    • 7.2.3.1 Oncology
    • 7.2.3.2 Infectious Diseases
    • 7.2.3.3 Immunology
    • 7.2.3.4 Neurobiology
    • 7.2.3.5 Stem Cells
    • 7.2.3.6 Other Research Areas

8 GLOBAL RESEARCH ANTIBODIES MARKET, BY APPLICATION

  • 8.1 Proteomics
  • 8.2 Drug Development
  • 8.3 Genomics

9 GLOBAL RESEARCH ANTIBODIES MARKET, BY GEOGRAPHY

  • 9.1 Overview
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 U.K.
    • 9.3.3 France
    • 9.3.4 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 China
    • 9.4.2 Japan
    • 9.4.3 India
    • 9.4.4 Rest of Asia Pacific
  • 9.5 Rest of the World
    • 9.5.1 Latin America
    • 9.5.2 Middle East and Africa

10 GLOBAL RESEARCH ANTIBODIES MARKET COMPETITIVE LANDSCAPE

  • 10.1 Overview
  • 10.2 Company Market Share
  • 10.3 Vendor Landscape
  • 10.4 Key Development Strategies

11 COMPANY PROFILES

  • 11.1 Thermo Fisher Scientific Inc.
    • 11.1.1 Overview
    • 11.1.2 Financial Performance
    • 11.1.3 Product Outlook
    • 11.1.4 Key Developments
  • 11.2 Merck Group
    • 11.2.1 Overview
    • 11.2.2 Financial Performance
    • 11.2.3 Product Outlook
    • 11.2.4 Key Developments
  • 11.3 Abcam PLC
    • 11.3.1 Overview
    • 11.3.2 Financial Performance
    • 11.3.3 Product Outlook
    • 11.3.4 Key Developments
  • 11.4 Becton, Dickinson and Company
    • 11.4.1 Overview
    • 11.4.2 Financial Performance
    • 11.4.3 Product Outlook
    • 11.4.4 Key Developments
  • 11.5 Cell Signaling Technology, Inc.
    • 11.5.1 Overview
    • 11.5.2 Financial Performance
    • 11.5.3 Product Outlook
    • 11.5.4 Key Developments
  • 11.6 Bio-Rad Laboratories, Inc.
    • 11.6.1 Overview
    • 11.6.2 Financial Performance
    • 11.6.3 Product Outlook
    • 11.6.4 Key Developments
  • 11.7 F. Hoffmann-La Roche Ltd
    • 11.7.1 Overview
    • 11.7.2 Financial Performance
    • 11.7.3 Product Outlook
    • 11.7.4 Key Developments
  • 11.8 Agilent Technologies, Inc.
    • 11.8.1 Overview
    • 11.8.2 Financial Performance
    • 11.8.3 Product Outlook
    • 11.8.4 Key Developments
  • 11.9 Danaher Corporation
    • 11.9.1 Overview
    • 11.9.2 Financial Performance
    • 11.9.3 Product Outlook
    • 11.9.4 Key Developments
  • 11.10 Lonza
    • 11.10.1 Overview
    • 11.10.2 Financial Performance
    • 11.10.3 Product Outlook
    • 11.10.4 Key Developments
  • 11.11 Genscript
    • 11.11.1 Overview
    • 11.11.2 Financial Performance
    • 11.11.3 Product Outlook
    • 11.11.4 Key Developments
  • 11.12 Perkinelmer, Inc.
    • 11.12.1 Overview
    • 11.12.2 Financial Performance
    • 11.12.3 Product Outlook
    • 11.12.4 Key Developments
  • 11.13 Biolegend, Inc.
    • 11.13.1 Overview
    • 11.13.2 Financial Performance
    • 11.13.3 Product Outlook
    • 11.13.4 Key Developments

12 KEY DEVELOPMENTS

  • 12.1 Product Launches/Developments
  • 12.2 Mergers and Acquisitions
  • 12.3 Business Expansions
  • 12.4 Partnerships and Collaborations

13 Appendix

  • 13.1 Related Research